Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look at the benefits of tiotropium, an approved drug for the
treatment of bronchospasm associated with COPD (chronic obstructive pulmonary disease), in a
population of patients with COPD who are of African American descent.